Department of Metabolic Medicine Graduate School of Medicine, Osaka University Suita Japan.
Department of Internal Medicine (I) Osaka Medical College Takatsuki Japan.
J Diabetes Investig. 2012 Dec 20;3(6):536-9. doi: 10.1111/jdi.12024. Epub 2012 Nov 30.
We have revised a part of the diagnostic criteria for fulminant type 1 diabetes. The new criteria were set both to express the essence of this disease of rapid increase of patients' blood glucose and to be highly sensitive to reduce the misdiagnosis. After analyzing the data of 382 patients with newly-diagnosed fulminant type 1 diabetes, we adopted the glycated hemoglobin (HbA1c) level of 8.7% (National Glycohemoglobin Standardization Program [NGSP] value). The new criterion indicates 100% of sensitivity and the best value by receiver operating characteristic curve analysis. In addition, we added a comment that 'This value (HbA1c <8.7% in NGSP) is not applicable for patients with previously diagnosed glucose intolerance' in the new criteria and also a comment that 'Association with human leukocyte antigen DRB104:05-DQB104:01 is reported' as a related finding. We did not revise the screening criteria and the other part of the diagnostic criteria, because they are still reliable.
我们修订了暴发性 1 型糖尿病的部分诊断标准。新的标准既体现了这种疾病血糖迅速升高的本质,又具有很高的敏感性,可以减少误诊。通过对 382 例新诊断的暴发性 1 型糖尿病患者的数据进行分析,我们采用了糖化血红蛋白(HbA1c)水平 8.7%(国家糖化血红蛋白标准化计划[NGSP]值)。新的标准表明,敏感性为 100%,通过接收者操作特征曲线分析得到最佳值。此外,我们在新标准中添加了一条注释,指出“该值(NGSP 中的 HbA1c<8.7%)不适用于以前诊断为葡萄糖耐量受损的患者”,并添加了一条注释,指出“与人类白细胞抗原 DRB104:05-DQB104:01 相关”作为相关发现。我们没有修订筛选标准和其他部分的诊断标准,因为它们仍然可靠。